P. Athanassiades

605 total citations
47 papers, 470 citations indexed

About

P. Athanassiades is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, P. Athanassiades has authored 47 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Surgery. Recurrent topics in P. Athanassiades's work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer and Skin Lesions (4 papers). P. Athanassiades is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer and Skin Lesions (4 papers). P. Athanassiades collaborates with scholars based in Greece, United States and Russia. P. Athanassiades's co-authors include P. Athanassiadou, Maria Gonidi, Dimitra Grapsa, Efstratios Patsouris, Pauline Athanassiadou, Meletios Α. Dimopoulos, Christos Papadimitriou, Αθανάσιος Γιαννόπουλος, Αchilles Anagnostopoulos and C Dimopoulos and has published in prestigious journals such as The Journal of Urology, Annals of Oncology and Urology.

In The Last Decade

P. Athanassiades

46 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Athanassiades Greece 12 179 139 93 85 71 47 470
Matthew P. Borst United States 8 149 0.8× 116 0.8× 46 0.5× 36 0.4× 65 0.9× 11 399
J. M. G. Bonfrer Netherlands 14 255 1.4× 202 1.5× 81 0.9× 80 0.9× 90 1.3× 25 670
Małgorzata Fuksiewicz Poland 14 170 0.9× 321 2.3× 70 0.8× 76 0.9× 81 1.1× 42 620
Ismael D.C.G. Silva Brazil 11 171 1.0× 153 1.1× 37 0.4× 48 0.6× 118 1.7× 17 533
Takachika Ozawa Japan 13 87 0.5× 118 0.8× 101 1.1× 135 1.6× 44 0.6× 28 417
Seyran Yiğit Türkiye 14 76 0.4× 181 1.3× 84 0.9× 74 0.9× 93 1.3× 43 433
Paweł Mach Germany 16 127 0.7× 186 1.3× 81 0.9× 53 0.6× 168 2.4× 59 646
Monica Verrico Italy 11 128 0.7× 251 1.8× 49 0.5× 74 0.9× 91 1.3× 31 484
Donna Dunn United States 5 170 0.9× 145 1.0× 54 0.6× 20 0.2× 93 1.3× 5 494
Alejandro Rojo‐Sebastián Spain 14 375 2.1× 122 0.9× 88 0.9× 75 0.9× 114 1.6× 18 686

Countries citing papers authored by P. Athanassiades

Since Specialization
Citations

This map shows the geographic impact of P. Athanassiades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Athanassiades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Athanassiades more than expected).

Fields of papers citing papers by P. Athanassiades

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Athanassiades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Athanassiades. The network helps show where P. Athanassiades may publish in the future.

Co-authorship network of co-authors of P. Athanassiades

This figure shows the co-authorship network connecting the top 25 collaborators of P. Athanassiades. A scholar is included among the top collaborators of P. Athanassiades based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Athanassiades. P. Athanassiades is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Athanassiadou, P., et al.. (2007). The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study. International Journal of Gynecological Cancer. 17(3). 697–704. 57 indexed citations
2.
Gonidi, Maria, et al.. (2005). Prognostic value of DNA analysis of prostate adenocarcinoma: correlation to clinicopathologic predictors.. PubMed. 24(2). 273–8. 7 indexed citations
3.
Γιαννόπουλος, Αθανάσιος, et al.. (2004). Expression of p120, Ki‐67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value. Cytopathology. 15(1). 25–31. 57 indexed citations
4.
Karakitsos, Petros, Christos Markopoulos, K. Aroni, et al.. (2001). p53 protein expression and oestrogen and progesterone receptor status in invasive ductal breast carcinomas. Cytopathology. 12(3). 197–202. 11 indexed citations
5.
Dimopoulos, Meletios Α., Evangelos Kostis, Αchilles Anagnostopoulos, et al.. (2000). Non-cryopreserved peripheral blood progenitor cells collected by a single very large-volume leukapheresis: A simplified and effective procedure for support of high-dose chemotherapy. Journal of Clinical Apheresis. 15(4). 236–241. 9 indexed citations
6.
Alevizaki, Maria, et al.. (2000). Cushing syndrome as the presenting feature of metastatic Leydig cell tumor of the testis. Urology. 56(1). 153–153. 5 indexed citations
7.
Dimopoulos, Meletios Α., Charalambos Deliveliotis, Lia A. Moulopoulos, et al.. (1998). Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel. Urology. 52(1). 56–60. 41 indexed citations
8.
Athanassiadou, P., et al.. (1998). Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours. European Journal of Cancer Prevention. 7(3). 225–231. 31 indexed citations
9.
Athanassiadou, P., et al.. (1998). Expression of Cathepsin D and pS2 in imprint smears of breast carcinoma. Cytopathology. 9(4). 240–247. 4 indexed citations
10.
Papadimitriou, Christos, Meletios Α. Dimopoulos, Αchilles Anagnostopoulos, et al.. (1998). Sequential Administration of Doxorubicin and Paclitaxel Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil Combination (CMF) in Women with Metastatic Breast Cancer. Oncology. 55(6). 533–537. 3 indexed citations
11.
Athanassiadou, Pauline, et al.. (1998). Cathepsin D immunoreactivity in ovarian cancer: Correlation with prognostic factors. Pathology & Oncology Research. 4(2). 103–107. 14 indexed citations
12.
Athanassiadou, P., et al.. (1997). Expression of Cathepsin-D, CA125 and Epidermal Growth Factor Receptor in Imprint Smears of Ovarian Carcinoma. Gynecologic and Obstetric Investigation. 43(2). 125–130. 1 indexed citations
13.
Papadimitriou, Christos, et al.. (1997). Late relapse of nonseminomatous germ cell tumor of the testis: Successful treatment with salvage chemotherapy alone. Urology. 49(3). 469–470. 3 indexed citations
14.
Athanassiadou, P., et al.. (1997). Immunocytochemical localization of Cathepsin D and CA 125 in ovarian cancer. International Journal of Gynecology & Obstetrics. 56(1). 31–37. 3 indexed citations
15.
Athanassiadou, P., et al.. (1996). Expression of Insulin‐Like Growth Factor‐I Receptor and Transferrin Receptor By Breast Cancer Cells In Pleural Effusion Smears. Cytopathology. 7(6). 400–405. 1 indexed citations
16.
Dimopoulos, Meletios Α., et al.. (1995). 9Complications and supportive therapy of multiple myeloma. Baillière s Clinical Haematology. 8(4). 845–852. 5 indexed citations
17.
Athanassiadou, P., et al.. (1995). Immunocytochemical Determination of EGFR, OV 632 and OC 125 in Primary Ovarian Cancer Patients. Oncology. 52(2). 145–149. 2 indexed citations
18.
Athanassiadou, Pauline, et al.. (1995). Antigen expression of alveolar macrophages in smokers and patients with lung diseases. Diagnostic Cytopathology. 12(1). 37–41. 7 indexed citations
20.
Athanassiadou, P., Katerina Kyrkou, L Antoniades, & P. Athanassiades. (1992). Cytological Evaluation of the Effect of Tamoxifen In Premenopausal and Post‐Menopausal Women With Primary Breast Cancer By Analysis of the Karyopyknotic Indices of Vaginal Smears. Cytopathology. 3(4). 203–208. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026